Introduction
The B cell antigen receptor (BCR) consists of membrane (m) IgM that is associated with heterodimers of Igα (CD79a) and Igβ (CD79b) subunits (1) (2) (3) . Cross-linking of BCR leads to activation of several protein tyrosine kinases (PTK), such as Src family kinases (Lyn, Blk and Fyn) and Syk kinase (4) (5) (6) . Phosphorylation of several proteins, including PTK themselves, ITAMs of Igα and Igβ, phospholipase C (PLC)-γ, phosphatidylinositol (PI) 3-kinase, Ras-GTPase-activating protein, Vav and Shc, are also induced after BCR cross-linking (7) (8) (9) (10) (11) (12) . One of the Src family kinases, Lyn, is expressed preferentially in hematopoietic cells, mainly B cells and monocytes/macrophages, and in the cells of neural tissues (13, 14) . From previous studies, Lyn is associated with cell surface receptors, such as the BCR complex, the high-affinity receptor for Fcε (FcεRI), CD40 and the lipopolysaccharide (LPS) receptor (CD14) (15) (16) (17) . It is known that Lyn is rapidly phosphorylated upon BCR cross-linking. The functional role of Lyn in BCR signaling was first demonstrated in cell lines.
taken from young lyn-deficient mice showed hyperproliferative response to anti-IgM cross-linking (22, 23) . Thus, we and other recent reports suggest a role of Lyn in the negative regulation of BCR signaling (22, 23) . Cross-linking of BCR by antigen may transmit strong signals for apoptosis in immature B cells unless Lyn does not play a role as a negative regulator through activation of FcγR or CD22 (24) . The lack of negative regulation by Lyn kinase may cause decreased numbers of conventional B cells and, consequently, a relative increase of Mac-1 ϩ B cells.
Btk (Bruton's tyrosine kinase) is expressed widely in hematopoietic cells, including nearly all stages of B cell development (25, 26) . However, Btk is found at negligible levels in T cells and is down-regulated in plasma cells (27) . Mutations in the btk gene at one or more sites have been linked to X chromosome-linked agammaglobulinemia (XLA) in human (28) . XLA is a severe immunodeficiency disease characterized by the deficiency of mature B cells and circulating Ig of all isotypes (29) . On the other hand, xid (CBA/N) mice, which carry a point mutation in the pleckstrin homology (PH) domain at Arg28 of Btk (30, 31) , show milder immunodeficiency than XLA. The xid mice exhibit reduced numbers of mature B cells (32) , reduced serum levels of IgM and IgG3 (33), disappearance of peritoneal CD5 ϩ B-1 cells (34), low proliferative response of anti-IgM and LPS stimulation in vitro (35, 36) , and low immune response to certain thymus-independent antigens in vivo (37) . In addition, from recent studies, Btkdeficient mice made by gene targeting showed a similar phenotype to that of xid mice (38, 39) . A Btk-deficient mutant of chicken B cell line DT40 exhibited abrogated Ca 2ϩ influx and IP 3 accumulation, and reduced tyrosine phosphorylation of PLC-γ2 (40) . Thus, Btk plays a critical role in the differentiation and intracellular signaling of B lymphocytes.
However, the interaction of Lyn and Btk is not yet clear in vivo. We established lyn-deficient xid mice, which had double null mutations of lyn and btk genes, and investigated how the lack of both Lyn and Btk affects B cell development, function and immune responses.
Methods

Generation of lyn-deficient xid mice
Lyn-deficient mice (lyn -/-) were generated as described (20) and B cells from these mice lack any detectable Lyn protein. CBA/N mice which carry the mutated btk (xid) gene were originally obtained from Japan SLC (Hamamatsu, Japan). Female CBA/N mice (xid/xid, homozygous for the mutated btk gene) were mated with male lyn-deficient mice. Subsequently, female F 1 mice (heterozygous for the mutated lyn and mutated btk gene) were mated with male F 1 mice (xid, heterozygous for the mutated lyn gene). In the next offspring, double mutant, lyn-deficient xid mice were expected and found in a ratio of 1:8. To detect the btk mutation, PCR-SSCP analysis was done by DNA obtained from the tail, using primers and protocols as described (31) .
Flow cytometry analysis
Single-cell suspensions from spleen, peritoneal cavity and bone marrow were prepared and stained by specific antibodies to various lymphocyte cell surface makers. Stained cells were analyzed by Epics XL-MCL (Coulter, Hialeah, FL) using Lysis software. mAb used for the staining were FITC-conjugated anti-mouse B220/CD45R and IgM, phycoerythrin (PE)-labeled anti-mouse B220/CD45R and CD5, and Cy-Chrome labeled anti-mouse B220. All reagents were purchased from PharMingen (San Diego, CA).
Measurement of serum Ig levels by ELISA For determinations of total IgM, IgG1, IgG2a, IgG2b and IgG3 in the serum of unimmunized mice, plates were coated with 10 µg/ml of isotype-specific goat anti-mouse antibodies, and diluted serum were incubated. After washing the plates, horseradish peroxide (HRP)-labeled isotype-specific antibodies (Southern Biotechnology Associates, Birmingham, AL) were added. For determination of anti-double-stranded DNA antibodies, plates were coated with 10 µg/ml of pUC19 plasmid DNA and diluted serum were incubated. Anti-doublestranded DNA antibodies were visualized with HRP-labeled total IgM ϩ IgG antibodies.
Cell culture and proliferation assay Splenic B cells were treated with anti-mouse Thy-1.2 mAb for 30 min on ice and then with complement for 30 min at 37°C for depletion of T cell. To remove adherent cells, cells were incubated at 37°C for 1 h and non-adherent cells were collected. About 90-95% of the isolated cells were found to express the B cell marker, B220. Cells were cultured in RPMI 1640 containing 5ϫ10 -5 M 2-mercaptoethanol and 10% heatinactivated FCS, at 37°C in 5% CO 2 in air atmosphere. Splenic B cells (1ϫ10 6 /ml, 100 µl) were placed in 96-well flat-bottom plates and cultured for 72 h with various stimuli. The cultures were pulsed for the last 6 h with 1 µCi/ml [ 3 H]thymidine. Various mitogens were used as described below: LPS at 10 µg/ml (Difco, Detroit, MI), goat F(abЈ) 2 anti-mouse IgM at 10 µg/ml (Southern Biotechnology Associates), recombinant IL-4 at 200 U/ml (R & D Systems, Minneapolis, MN) and soluble CD40 ligand CD8 fusion protein (CD40L) which was the culture supernatant (33% v/v) produced from a myeloma cell line (41) (kindly provided by Dr P. Lane, Basel Institute for Immunology).
Immunohistochemistry and histology
For histological study, tissues were fixed in formalin for 1 day and embedded in paraffin. Sections (5 µm thick) were stained with hematoxylin & eosin. Frozen sections (5 µm thick) from spleens in OCT compound were sliced with a cryostat and fixed in cold acetone in 30 min. Sections were stained with FITC-Mac-1 antibody (PharMingen).
Immunization with NP-CG and measurement of NP-specific antibody Mice (5-7 weeks old) were immunized i.p. with 100 µg of NPcoupled chicken gammaglobulin (NP-CG) absorbed to alum and boosted with the same dose of antigen in PBS at day 21 (kindly provided by Drs T. Kaisho and K. Rajewsky, Institute for Genetics, University of Cologne). Serum titers of NPspecific IgG1 were measured by ELISA, using the plates coated with NP 14 -BSA, and visualized with HRP-labeled IgG1 antibody.
Results
The reduced numbers of mature B cells and peritoneal B-1 cells in lyn-deficient xid mice Lyn-deficient xid mice appeared to be healthy and bred offspring normally. Since Lyn and Btk are associated with BCR-mediated signaling, we investigated B cell lineage and development by flow cytometry. As previously described, the aged lyn-deficient mice (Ͼ3-4 months old) showed splenomegaly (20) (21) (22) . On the other hand, age-matched old lyndeficient xid mice did not develop any splenomegaly, but had much smaller spleens as compared with those of normal mice. Splenomegaly in lyn-deficient mice at old age was mainly due to the massive increase of Mac-1 ϩ , cytoplasmic IgM ϩ lymphoblast-like cells (20) . However, the numbers of mature B cells decreased in lyn-deficient mice with age, compared to the age-matched wild-type mice. At young age (6-8 weeks old), reduction of the numbers of splenic B cells in lyn-deficient mice was mild, but a severe decrease in the numbers of mature B cells was evident in the spleens of lyndeficient xid mice in comparison with wild-type, xid or lyndeficient mice (Fig. 1a and Table 1 ). The numbers of B220 ϩ / IgM ϩ B cells in the spleen of 6-to 8-week-old double mutant mice were~16-fold reduced as compared to wild-type mice and~7-fold reduced compared to xid or lyn-deficient mice (Table 1 ). In addition, the B220 ϩ /IgM ϩ B cells in lymph nodes of double mutant mice were also greatly reduced compared to those of wild-type mice (data not shown). On the other hand, in bone marrow, the numbers of pre-B cells and immature B cells were not affected, but the double mutant mice lack a large part of IgM ϩ /B220 high mature B cells, which were also markedly reduced in xid-and lyn-deficient mice as described previously (20) (21) (22) 42) (Fig. 1b) . These data indicate that maturation of B cells from the immature stage was severely affected synergistically by Lyn-and Btk-deficiency in double mutant mice and suggest that Lyn and Btk may partly play a distinct role in B cell maturation. In the peritoneal cavity, CD5 ϩ B-1 cells (CD5 ϩ and B220 low~ϩ ) disappeared in xid mice as reported previously (34) and were also missing in double mutant mice (Fig. 1c) . Mature B-2 (B220 ϩ , CD5 -) cells markedly decreased also in the peritoneal cavity of lyndeficient xid mice. The data indicate that double mutant mice had a severe reduction of mature B-2 cells as well as lack of CD5 ϩ B-1 cells.
Serum levels of IgM and IgG subclasses in lyn-deficient xid mice
The serum levels of IgM, IgG1, IgG2a, IgG2b and IgG3 were measured in wild-type, xid, lyn-deficient, and lyn-deficient xid mice at 6 weeks old (Fig. 2) . As previously described, xid mice had low serum levels of IgM and IgG3 (33) . Double mutant mice also had reduced serum levels of IgM and IgG3 ( Fig. 2a and b) . Aged lyn-deficient mice (Ͼ4 months) exhibited elevated serum levels of Ig (mainly IgM), autoreactive antibodies, such as anti-DNA antibody, and autoimmune glomerulonephritis (20) (21) (22) . However, aged lyn-deficient xid mice (4 months old) showed a reduced serum level of IgM (Fig. 2a) and were negative for anti-double-stranded DNA antibody (Fig. 3) . The double mutant mice also showed reduced serum level of IgG3, which is comparable to the level of xid mice.
However, the serum levels of IgG1, IgG2a and IgG2b did not differ among each group of mice (Fig. 2b) .
Abnormal Mac-1 ϩ cells disappeared in lyn-deficient xid mice Lyn-deficient mice developed splenomegaly and glomerulonephritis with age (20) (21) (22) . Lymphoid follicles were missing in spleens of 6-month-old lyn-deficient mice and large lymphoblast-like cells were accumulated in white pulp (Fig.  4B) . On the other hand, double mutant mice showed normal size of white pulp and formed lymphoid follicles similar to the normal littermates (Fig. 4A and C) . Unusual lymphoblast-like cells, which expressed Mac-1 on the surface and contained cytoplasmic IgM, were seen in lyn-deficient mice (Fig. 4D) . However, the double mutant mice contained very few Mac-1 ϩ cells (Fig. 4E) . Thus, the absence of Btk diminished Mac-1 ϩ cells which were present in the spleens of old lyn-deficient mice. Double mutant mice did not develop any autoimmune nephritis at old age, although lyn-deficient mice developed glomerulonephritis with age (data not shown).
In vitro proliferative responses to various stimuli of lyn-deficient xid mice
As previously reported, peripheral B cells from xid mice show a low proliferative response to anti-IgM antibody or LPS stimulation in vitro (35, 36) . B cells from lyn-deficient mice at old age also showed low proliferative response upon stimulation with surface IgM cross-linking, because of the decrease in numbers of mature B cells and the accumulation of abnormal lymphoblast-like cells (20) . However, B cells from young (4-8 weeks old) lyn-deficient mice showed a hyperproliferative response to anti-IgM stimulation (22, 23) . Proliferative response to anti-IgM stimulation of B cells from xid mice of 6 weeks old was low, compared to the age-matched normal littermates (Fig. 5) . B cells of 6-week-old lyn-deficient mice showed a higher proliferative response than that of normal littermates, as previously reported (22, 23) . On the other hand, response by B cells from double mutant mice was low to antiIgM stimulation, which was at a similar level to that of xid mice (Fig. 5) . In the case of LPS response, lyn-deficient B cells showed a slightly lower response compared to that of control B cells (Fig. 5) . However, B cells from xid mice showed a very low response to LPS-induced proliferation, as previously described (36) . B cells from double mutant mice also showed very low response to LPS stimulation, that was similar level to that of xid mice (Fig. 5) . Addition of either IL-4 or CD40L partially recovered proliferative responses of B cells of xid and double mutant mice to anti-IgM and LPS stimulation ( Antibody production in lyn-deficient xid mice upon immunization with T-dependent antigen Mice were immunized with NP-CG and NP-specific IgG1 responses were measured. As shown in Fig. 6 , the titers of NP-specific IgG1 antibodies of lyn-deficient xid mice were lower than those of wild-type, but at a similar level to those of xid and lyn-deficient mice. These results suggested that lyn-deficient xid mice can mount antibody production upon T-dependent antigen despite of the marked decrease in mature B cells.
Discussion
In the present study, the lyn-deficient xid mice exhibited (i) greatly reduced numbers of peripheral mature B cells, (ii) disappearance of autoimmune symptoms which are characteristic for lyn-deficient mice, such as the elevated serum level of IgM, splenomegaly and production of autoantibodies, and (iii) low proliferative response to anti-IgM or LPS stimulation in vitro, at a similar level to that of xid mice.
Btk is known to play an important role in B cell development. In mouse, the transition from immature to mature B cells is Cells from spleens of nine mice aged 6-8 weeks old were counted. The values represent the mean ϮSD. impaired by the absence of Btk (38, 39) . Accordingly, btkdeficient or xid mice exhibit reduced numbers of mature B cells (Fig. 1) . Lyn-deficient mice also exhibited reduced numbers of mature B cells and transition from immature to mature B cells was impaired (Fig. 1) . However, lyn-deficient xid mice showed severely decreased numbers of mature B cells, more than the reduction in either lyn-deficient or xid mice (Table 1 and Fig. 1) , suggesting that the pathways affected by Lyn-deficiency and Btk-deficiency seem to be partly distinct each other and synergistically effective at the differentiation stage from immature to mature B cells. It has been reported that B cells in lyn-deficient mice show a hyperproliferative response to anti-IgM stimulation (22, 23) and an enhanced MAP kinase activation (22) , proposing that Lyn may be involved in the negative regulation of BCR signaling through SH2-containing tyrosine phosphatases such as SHP-1 (24) . Upon co-ligation of BCR complex and coreceptors by antigen or antigen-antibody complex, activated Lyn has been reported to phosphorylate tyrosine residues on ITIM of CD22 (43) or FcγR (44) . The SH2-containing phosphatases can be then recruited to the receptor complex and exert negative regulation by dephosphorylation (45) . Thus, in the absence of negative regulation by Lyn kinase, BCR may transmit the strong signals for apoptosis in immature B cells and cause reduced numbers of conventional mature B cells (22, 23) . Moreover, signals transmitted by Btk play an important role in the transition from immature to mature B cells. Thus, the lack of Btk also causes reduced numbers of peripheral mature B cells (38, 39) . Therefore both Lyn and Btk Why did autoimmune symptoms disappear in lyn-deficient xid mice? One possibility is that autoimmune symptoms in lyn-deficient mice may be caused by not only autoantibodyproducing conventional B (B-2) cells, which were discussed in the previous report (20) , but also by B-1 cells that are known to produce autoantibodies (46) . B-1 cells are present mainly in the peritoneal cavity in adult mice and maintained by self-renewal (47) . B-1 cells produce mainly IgM of low affinity and broad specificity for bacterial components such as LPS. In addition, B-1 cells have been reported to produce autoantibodies and to associate with several autoimmune mouse strains (47, 48) . On the other hand, xid mice show no detection of CD5 ϩ B-1 cells (Fig. 1c) and reduced serum levels of IgM and IgG3 (Fig. 2) . Several autoimmune mice have been mated with xid mice (49) (50) (51) (52) (53) . Surprisingly, autoimmune symptoms disappeared in the autoimmune prone mice, which carried the xid gene at the same time. Motheaten (me) or viable motheaten mice, which lack SHP-1 (also called PTP1C or HCP) phosphatase activity because of spliced mutant SHP-1 protein (54, 55) , exhibit greatly elevated serum levels of IgM, autoantibody, splenomegaly and autoimmune disease (56, 57) . Although the numbers of the conventional B cells are greatly reduced, plasma cells and CD5 ϩ B-1 cells are accumulated in spleen and lymph nodes of motheaten mice (58) . However, in the motheaten mice carrying the xid gene (me/xid ), CD5 ϩ B-1 cells disappeared and autoimmune symptoms, such as splenomegaly, elevated serum level of IgM and production of autoantibody, were not observed (49) . These results suggest that autoimmune disease of me mice is mainly caused by the increase of B-1 cells and that B-1 cells were completely abolished in the absence of Btk. Similarly, CD22-deficient mice, which lack negative regulation for BCR signaling through the recruitment of SHP-1 to the antigen-receptor complex, revealed augmented BCR signal transduction, expanded peritoneal B-1 cells and increased serum titers of autoantibodies (59, 60) . Aged lyn-deficient mice developed splenomegaly, high titer of serum IgM, production of autoantibodies and expanded population of B lymphoblasts of CD5 ϩ B-1 lineage (20, 22) . It has been reported that splenomegaly of lyn-deficient mice was mainly due to the accumulation of Mac-1 ϩ lymphoblast-like cells, which contained IgM in cytoplasm and expressed low levels of B220 (20) . These cells may resemble the subtype of B-1 cells which had been reported to produce autoantibodies (46) . The lyn-deficient mice may have an expanded population of such B-1 cells. The present study clearly showed that lack of Btk induced disappearance of CD5 ϩ B-1 cells, accumulation of Mac-1 ϩ lymphoblast-like cells in the spleen and autoimmune symptoms in lyn-deficient mice. These results suggested a possibility that autoimmune disease in lyndeficient mice may be caused by the expansion of the population belonged to the cells of the B-1 lineage. Alternatively, mature B-2 cells of lyn-deficient mice might have a low threshold of sensitivity to antigen stimulation because of a lack of negative regulation mediated by Lyn. Thus, some B-2 cells might respond to cross-reactive autoantigen at a low concentration and differentiate into autoantigen-reactive IgMproducing cells. Btk plays a crucial role also in signal transduction in B-2 cells and, therefore, the production of autoantibodies may have been turned off in lyn-deficient xid mice. This possibility might be unlikely since the level of immune response to T-dependent antigen by lyn-deficient xid mice was similar to that of lyn-deficient or xid mice (Fig. 6) , and the immune response by lyn-deficient mice to the T-dependent and T-independent antigen was not strongly augmented, but it was rather similar to or lower than that of normal mice (20, 21) .
B cells of the lyn-deficient xid mice showed low proliferative response to anti-IgM or LPS stimulation similarly to xid mice (Fig. 5) . In addition, serum levels of IgM and IgG subclasses of the double mutant mice were similar to those of xid mice (Fig. 2) . These results indicated that some of the B cell responses in the double mutant mice are affected by the absence of Btk, but not Lyn. These findings suggest that the interaction between Lyn and Btk is partly in tandem at BCR signaling pathways besides their distinct roles in B cell maturation as described above. Lyn is physically associated with the BCR and is rapidly phosphorylated upon BCR cross-linking (4-6). The activated Lyn thus interacts with and phosphorylates Syk, PI-3 kinase and ITAM motifs of Igα and Igβ (3). On the other hand, Btk is phosphorylated and enzymatically activated also after BCR stimulation (61) (62) (63) , but the activation of Btk appears to be preceded by that of Lyn (63) (64) (65) . It has been previously demonstrated that the activation of Btk occurs indirectly by Src family kinases (64, 65) . However, the precise mechanism of the interaction between Lyn and Btk is not yet clear. The experiments performed with the chicken B cell line DT40 suggested a possibility that Btk is partly in downstream of Lyn at BCR signaling pathways (40) . Lyn-deficient chicken B cells exhibited delayed Ca 2ϩ influx, but enhanced IP 3 accumulation after anti-IgM stimulation (18) . On the contrary, Btk-deficient cells exhibited no Ca 2ϩ influx and no IP 3 accumulation (40). Moreover, it was shown that the activation of Lyn is independent of Btk. The present study showed that some, but not all, abnormal B cell responses in lyn-deficient xid mice were corrected by the absence of Btk. Thus, it might be concluded that the interaction between Lyn and Btk is partly in tandem, and Btk is probably downstream of Lyn at BCR signaling pathways.
Taken together, Lyn and Btk play an important role in B cell development and BCR signaling. Lyn-deficient xid mice, presented in this study, will be a good model for the study on the interaction between Lyn and Btk upon BCR stimulation, and also on analysis of abnormality in BCR-mediated signal cascade in autoimmune diseases.
